Global Reach Expansion AccessClosure's growing international distribution of Mynx vascular closure devices, combined with its exclusive US distribution of the Flash Ostial System, creates opportunities to expand through Cardinal Health's hospital network. Target interventional cardiology and peripheral vascular labs in new regions with bundled vascular access and catheter adoption programs.

Cath Lab Focus The Mynx Ace and MynxGrip address vascular access challenges in cath lab procedures, indicating strong demand in interventional cardiology and vascular surgery settings. Propose clinician education campaigns, peer-led case studies, and outcomes data to accelerate adoption and increase share of wallet with hospitals.

Ostial Synergy Being the exclusive US distributor of the Flash Ostial System Dual Balloon Angioplasty Catheter enables integrated ostial lesion solutions for cath labs. Recommend bundled procurement, joint training, and co-marketing to drive adoption of both closure and ostial tools among target accounts.

Channel Advantage As a Cardinal Health company, AccessClosure can leverage a deep distributor network and hospital contracting capabilities to simplify procurement and scale pilots. Opportunities include joint go-to-market programs, volume-based pricing discussions, and faster onboarding with health systems.

Innovation Roadmap With a history of product launches and ongoing vascular closure development, there is potential to upsell newer generations and accessories to existing customers and to expand into adjacent vascular devices. Action items include clinician feedback programs, pilot deployments for new devices, and expanded product-line conversations with procurement.